APOC3 and diabetes mellitus: Importantly, APOC3 ASO treatment reduced diabetes-associated glomerular hypertrophy, glomerular perilipin 2 staining, macrophage accumulation, and lipid-loaded macrophage accumulation (Figure 6, E–I).